Tetraphase Pharmaceuticals
TTPH · Chemicals & Drugs · NASDAQ · in our data March 20, 2013 to July 28, 2020 (7.4 years)
The first trading day in our data for Tetraphase Pharmaceuticals is March 20, 2013 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on July 16, 2015, the market valued it at $1.9 billion. It ended in a collapse: the last trade was $2.20, -99.8% from its split-adjusted high. The delisting record says: merged or acquired.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2013.
Could you have seen it coming? Play COVIDAlso gone in 2020: Chemicals & Drugs
- Avon Products peaked at $21.8 billion
- Immunomedics Inc peaked at $20.3 billion
- Myokardia Inc peaked at $12.0 billion
- Medicines Co (the) peaked at $6.8 billion
- Akorn Inc peaked at $6.4 billion
- PDL Biopharma Inc peaked at $6.3 billion
